Autonomous Molecular Discovery
ModelMole is the natural evolution in AI drug discovery.
The Next Evolution
in Drug Discovery
Most AI systems are limited by their training data; they can only extrapolate from what they have seen.
ModelMole is Different.
By integrating high-accuracy physics-based methods with state-of-the-art AI, we can look further from the known chemical space. This allows ModelMole to "look into the dark" where datasets are sparse, identifying highly novel, effective, and patentable solutions that pure machine learning models miss.
We call it Intelligent multi-model orchestration
The Intelligent Orchestration
Our proprietary Swarm AI system doesn't rely on a single model. It utilises a network of multiple AI systems that cross-reference predictions to identify confidence levels.
ModelMole’s automatic active learning loop ensures high accuracy and creates a formidable competitive moat that grows stronger with every problem it solves, rapidly improving the system over time and with every new problem.
The ModelMole Platform
Most drug discovery platforms are either narrow point solutions or complex systems tied to specific vendors or infrastructure.
ModelMole is fully autonomous and infrastructure-agnostic—designed to run anywhere from enterprise clusters to a single workstation. ModelMole has a unique way of following up the user to achieve an optimal result of a drug discovery platform.
Autonomous Swarm Intelligence
Fully customisable
High-accuracy physics-based methods
Intelligent multi-model orchestration
Autonomous end-to-end process
Full project support available
Start using ModelMole today!
By integrating high-accuracy physics-based methods with state-of-the-art AI, ModelMole can look further from the known chemical space.
"Look into the dark"
where datasets are sparse
→ Identifying highly novel, effective, and patentable solutions
- Multiple AI systems cross-reference predictions to identify confidence levels
- Automatic gap-filling using computational chemistry
- Automatic active learning loop
- Grows stronger with every problem solved
The Competitive Moat
Automatic improvement loop
High accuracy with every problem
Stronger with each iteration
Compounding competitive advantage
Years of improvement
Continuously evolving system
End-to-End Discovery
Our Work
The ModelMole platform rapidly assesses biological systems and predicts promising candidates that might be missed by traditional approaches, opening doors to innovative biotech and pharmaceutical breakthroughs.
Our platform is continuously used by our clients to develop and optimise new proprietary and collaborative drugs candidates.
Discovery Pipeline
Candidates across discovery, development and approval
| Project | Therapeutic Area | Species | Discovery | Lead Opt. | In Vitro | Preclinical | Phase 1 | Phase 2 | Phase 3 | Approval |
|---|---|---|---|---|---|---|---|---|---|---|
| Targeted radiotherapy | Oncology | Human |
Preclinical
|
|||||||
| Collagen repair | Cosmetics | Human |
Preclinical
|
|||||||
| Antimicrobial Peptides | Antibiotic | Human |
In Vitro
|
|||||||
| Antimicrobial Peptide-Drug Conjugates | Antibiotic | Human |
Discovery
|
|||||||
| Transcription Regulator | Oncology | Human |
Discovery
|
|||||||
| Project | Therapeutic Area | Species | Discovery | Lead Opt. | In Vitro | In Vivo | Field Trials | Vet Approval |
|---|---|---|---|---|---|---|---|---|
| Sea lice vaccine | Antiparasitic | Salmon |
In Vivo
|
|||||
| Antimicrobial Peptides | Antibiotic | Salmon |
Discovery
|
|||||
